118 related articles for article (PubMed ID: 2203852)
1. Intraocular pressure lowering effects of the renin inhibitor ABBOTT-64662 diacetate in animals.
Giardina WJ; Kleinert HD; Ebert DM; Wismer CT; Chekal MA; Stein HH
J Ocul Pharmacol; 1990; 6(2):75-83. PubMed ID: 2203852
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of three different potent renin inhibitors in primates.
Clozel JP; Fischli W
Hypertension; 1993 Jul; 22(1):9-17. PubMed ID: 8319997
[TBL] [Abstract][Full Text] [Related]
3. KRI-1314: an orally effective inhibitor of human renin.
Etoh Y; Miyazaki M; Saitoh H; Toda N
Jpn J Pharmacol; 1993 Sep; 63(1):109-19. PubMed ID: 8271523
[TBL] [Abstract][Full Text] [Related]
4. Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilat.
Neutel JM; Luther RR; Boger RS; Weber MA
Am Heart J; 1991 Oct; 122(4 Pt 1):1094-100. PubMed ID: 1656720
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological properties of YM-21095, a potent and highly specific renin inhibitor.
Shibasaki M; Asano M; Fukunaga Y; Usui T; Ichihara M; Murakami Y; Nakano K; Fujikura T
Am J Hypertens; 1991 Dec; 4(12 Pt 1):932-8. PubMed ID: 1815649
[TBL] [Abstract][Full Text] [Related]
6. Prolonged duration of blood pressure response to enalkiren, the novel dipeptide renin inhibitor, in essential hypertension.
Boger RS; Glassman HN; Cavanaugh JH; Schmitz PJ; Lamm J; Moyse D; Cohen A; Kleinert HD; Luther RR
Hypertension; 1990 Jun; 15(6 Pt 2):835-40. PubMed ID: 2190927
[TBL] [Abstract][Full Text] [Related]
7. Effect of SPP 635, a renin inhibitor, on intraocular pressure in glaucomatous monkey eyes.
Wang RF; Podos SM; Serle JB; Baltatu OC
Exp Eye Res; 2012 Jan; 94(1):146-9. PubMed ID: 22173206
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a new renin inhibitor). I: Single dose study.
Gupta SK; Granneman GR; Boger RS; Hollenberg NK; Luther RR
Drug Metab Dispos; 1992; 20(6):821-5. PubMed ID: 1362933
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic infusion of renin inhibitor A-64662 in sodium-depleted monkeys.
Verburg KM; Kleinert HD; Kadam JR; Chekal MA; Mento PF; Wilkes BM
Hypertension; 1989 Mar; 13(3):262-72. PubMed ID: 2646217
[TBL] [Abstract][Full Text] [Related]
10. Effects of topical H-7 on outflow facility, intraocular pressure, and corneal thickness in monkeys.
Tian B; Wang RF; Podos SM; Kaufman PL
Arch Ophthalmol; 2004 Aug; 122(8):1171-7. PubMed ID: 15302658
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular actions of the primate-selective renin inhibitor, A-62198.
Kleinert HD; Martin D; Chekal M; Young G; Rosenberg S; Plattner JJ; Perun TJ
J Pharmacol Exp Ther; 1988 Sep; 246(3):975-9. PubMed ID: 3047366
[TBL] [Abstract][Full Text] [Related]
12. Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys.
Tokushige H; Inatani M; Nemoto S; Sakaki H; Katayama K; Uehata M; Tanihara H
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3216-22. PubMed ID: 17591891
[TBL] [Abstract][Full Text] [Related]
13. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
[TBL] [Abstract][Full Text] [Related]
14. Effects of topical ethacrynic acid adducts on intraocular pressure in rabbits and monkeys.
Tingey DP; Schroeder A; Epstein MP; Epstein DL
Arch Ophthalmol; 1992 May; 110(5):699-702. PubMed ID: 1580849
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans.
Ishii K; Tomidokoro A; Nagahara M; Tamaki Y; Kanno M; Fukaya Y; Araie M
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2957-63. PubMed ID: 11687542
[TBL] [Abstract][Full Text] [Related]
16. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.
Ryan MJ; Hicks GW; Batley BL; Rapundalo ST; Patt WC; Taylor DG; Keiser JA
J Pharmacol Exp Ther; 1994 Jan; 268(1):372-9. PubMed ID: 8301578
[TBL] [Abstract][Full Text] [Related]
17. Effects of the renin inhibitor A-64662 in monkeys and rats with varying baseline plasma renin activity.
Kleinert HD; Martin D; Chekal MA; Kadam J; Luly JR; Plattner JJ; Perun TJ; Luther RR
Hypertension; 1988 Jun; 11(6 Pt 2):613-9. PubMed ID: 3292414
[TBL] [Abstract][Full Text] [Related]
18. Human renin inhibiting dipeptide.
Toda N; Miyazaki M; Etoh Y; Kubota T; Iizuka K
Eur J Pharmacol; 1986 Oct; 129(3):393-6. PubMed ID: 3536533
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and humoral effects of the new renin inhibitor enalkiren in normal humans.
Delabays A; Nussberger J; Porchet M; Waeber B; Hoyos P; Boger R; Glassman H; Kleinert HD; Luther R; Brunner HR
Hypertension; 1989 Jun; 13(6 Pt 2):941-7. PubMed ID: 2661434
[TBL] [Abstract][Full Text] [Related]
20. A pharmacodynamic study of the renin inhibitor SR 43,845, administered intratracheally in conscious cynomolgus monkeys.
Lacour C; Roccon A; Cazaubon C; Richaud JP; Segondy D; Nisato D
J Hypertens Suppl; 1991 Dec; 9(6):S384-5. PubMed ID: 1819002
[No Abstract] [Full Text] [Related]
[Next] [New Search]
